DOUGLAS E. WILLIAMS - 11 Nov 2024 Form 4 Insider Report for Climb Bio, Inc. (CLYM)

Role
Director
Signature
Emily Pimblett, as Attorney-in-Fact
Issuer symbol
CLYM
Transactions as of
11 Nov 2024
Net transactions value
$0
Form type
4
Filing time
12 Nov 2024, 17:47:55 UTC
Previous filing
12 Nov 2024
Next filing
19 Mar 2025
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CLYM Stock Option (Right to Buy) Award $0 +20,000 $0.000000 20,000 11 Nov 2024 Common Stock 20,000 $4.06 Direct F1
transaction CLYM Stock Option (Right to Buy) Award $0 +6,291 $0.000000 6,291 11 Nov 2024 Common Stock 6,291 $4.06 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares underlying the option vest in equal monthly installments from November 8, 2024 (the "Vesting Commencement Date") until the third anniversary of the Vesting Commencement Date, subject to the Reporting Person's continued service.
F2 The shares underlying the option vest on the earlier of June 26, 2025 or the day immediately prior to the next annual meeting of stockholders, subject to the Reporting Person's continued service.